CR10912A - Preparacion framaceutica para reducir la endometriosis - Google Patents
Preparacion framaceutica para reducir la endometriosisInfo
- Publication number
- CR10912A CR10912A CR10912A CR10912A CR10912A CR 10912 A CR10912 A CR 10912A CR 10912 A CR10912 A CR 10912A CR 10912 A CR10912 A CR 10912A CR 10912 A CR10912 A CR 10912A
- Authority
- CR
- Costa Rica
- Prior art keywords
- framaceutical
- preparation
- endometriosis
- reduce
- reduce endometriosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Una composicion farmaceutica para el tratamiento de endometrisis sin reducir la densidad osea contiene un gestageno con eficacia antiandrogenica, con preferencia 17a-cianometil-17B-hidroxiestra-4,9-dien-3-ona (dienogest), acetato de ciproterona o acetato de cloromadinona en una dosis diaria que es como maximo el doble de la dosis inhibidora de la ovulacion, junto con uno o varios excipientes/portadores farmaceuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07004202A EP1977752A1 (de) | 2007-03-01 | 2007-03-01 | Pharmazeutische Zubereitung zur Verminderung der Endometriose |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10912A true CR10912A (es) | 2009-08-13 |
Family
ID=38045772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10912A CR10912A (es) | 2007-03-01 | 2009-07-03 | Preparacion framaceutica para reducir la endometriosis |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP1977752A1 (es) |
JP (1) | JP2010520159A (es) |
KR (1) | KR20090119829A (es) |
CN (1) | CN101583364A (es) |
AU (1) | AU2008221012A1 (es) |
BR (1) | BRPI0806598A2 (es) |
CA (1) | CA2673936A1 (es) |
CO (1) | CO6190606A2 (es) |
CR (1) | CR10912A (es) |
DO (1) | DOP2009000171A (es) |
EA (1) | EA200900829A1 (es) |
EC (1) | ECSP099482A (es) |
MA (1) | MA31162B1 (es) |
MX (1) | MX2009007259A (es) |
NZ (1) | NZ577761A (es) |
SV (1) | SV2009003324A (es) |
TN (1) | TN2009000263A1 (es) |
WO (1) | WO2008104342A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101874806A (zh) * | 2009-04-29 | 2010-11-03 | 北京本草天源药物研究院 | 一种地诺孕素固体制剂 |
CN102670519B (zh) * | 2011-03-16 | 2014-06-11 | 重庆莱美药业股份有限公司 | 一种可快速溶出的地诺孕素口服制剂及其制备方法 |
CN103304619B (zh) * | 2013-06-08 | 2015-12-02 | 西藏海思科药业集团股份有限公司 | 一种地诺孕素化合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4426601A1 (de) * | 1994-07-27 | 1996-02-01 | Schering Ag | Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri |
EP1535618A1 (en) * | 2003-11-26 | 2005-06-01 | Schering Aktiengesellschaft | Pharmaceutical preparation for continuous hormonal treatment over a period of longer than 21-28 days comprising two estrogen and/or progestin compositions |
MY151322A (en) * | 2004-04-30 | 2014-05-15 | Bayer Ip Gmbh | Management of breakthrough bleeding in extended hormonal contraceptive regimens |
DE102004026679A1 (de) * | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat |
EP1655031A1 (de) * | 2004-10-08 | 2006-05-10 | Schering AG | Dienogest enthaltendes Langzeit-Verfahren zur Empfängnisverhütung |
-
2007
- 2007-03-01 EP EP07004202A patent/EP1977752A1/de not_active Withdrawn
-
2008
- 2008-02-23 JP JP2009551120A patent/JP2010520159A/ja active Pending
- 2008-02-23 EA EA200900829A patent/EA200900829A1/ru unknown
- 2008-02-23 EP EP08707797A patent/EP2059248A1/de not_active Ceased
- 2008-02-23 KR KR1020097014169A patent/KR20090119829A/ko not_active Application Discontinuation
- 2008-02-23 BR BRPI0806598-5A patent/BRPI0806598A2/pt not_active IP Right Cessation
- 2008-02-23 AU AU2008221012A patent/AU2008221012A1/en not_active Abandoned
- 2008-02-23 WO PCT/EP2008/001451 patent/WO2008104342A1/de active Application Filing
- 2008-02-23 CN CNA2008800023330A patent/CN101583364A/zh active Pending
- 2008-02-23 NZ NZ577761A patent/NZ577761A/en not_active IP Right Cessation
- 2008-02-23 CA CA002673936A patent/CA2673936A1/en not_active Abandoned
- 2008-02-23 MX MX2009007259A patent/MX2009007259A/es unknown
-
2009
- 2009-06-24 TN TNP2009000263A patent/TN2009000263A1/fr unknown
- 2009-07-03 SV SV2009003324A patent/SV2009003324A/es not_active Application Discontinuation
- 2009-07-03 CO CO09068629A patent/CO6190606A2/es not_active Application Discontinuation
- 2009-07-03 EC EC2009009482A patent/ECSP099482A/es unknown
- 2009-07-03 CR CR10912A patent/CR10912A/es unknown
- 2009-07-03 DO DO2009000171A patent/DOP2009000171A/es unknown
- 2009-08-04 MA MA32138A patent/MA31162B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
NZ577761A (en) | 2012-03-30 |
ECSP099482A (es) | 2009-08-28 |
CN101583364A (zh) | 2009-11-18 |
WO2008104342A1 (de) | 2008-09-04 |
AU2008221012A1 (en) | 2008-09-04 |
SV2009003324A (es) | 2009-10-02 |
CA2673936A1 (en) | 2008-09-04 |
DOP2009000171A (es) | 2009-08-31 |
EP2059248A1 (de) | 2009-05-20 |
JP2010520159A (ja) | 2010-06-10 |
EP1977752A1 (de) | 2008-10-08 |
MX2009007259A (es) | 2009-07-10 |
EA200900829A1 (ru) | 2010-02-26 |
CO6190606A2 (es) | 2010-08-19 |
MA31162B1 (fr) | 2010-02-01 |
TN2009000263A1 (en) | 2010-10-18 |
BRPI0806598A2 (pt) | 2014-05-06 |
KR20090119829A (ko) | 2009-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011003266A1 (es) | Compuestos derivados de imidazolidin-2-ona, con actividad inhibidora de 17alfa-hidroxilasa/liasa-c17,20; composicion farmaceutica que los comprende; y uso en el tratamiento de inflamacion o cancer, entre otras. | |
UY33343A (es) | Formas de dosificación sólidas orales con dosis muy bajas para la hrt | |
NZ594022A (en) | Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof | |
ES2916649T1 (es) | Composiciones y usos para el tratamiento de la esclerosis múltiple | |
ES2693085T1 (es) | Uso de estriol en bajas dosis | |
MY160768A (en) | Use of salvia miltiorrhiza composition in preparing drugs for secondary prevention of coronary heart disease | |
CL2012000754A1 (es) | Compuestos derivados de benzoxazepina condensadas con pirazolilo o imidazolilo, inhibidores de la actividad de la quinasa pi3; composicion farmaceutica que comprende un compuesto; y su uso en la preparacion de medicamentos para el tratamiento del cancer. | |
UY32260A (es) | Forma de dosificación farmacéutica que comprende nifedipino o nisoldipino y un antagonista de angiotensina ii y/o diuretico | |
ECSP088123A (es) | Anticoncepcion oral con trimegestona | |
UY30461A1 (es) | Composicion farmacéutica para la anticoncepcion y para reducir el riesgo de malformaciones congénitas. | |
TN2011000651A1 (en) | Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine their preparation and their therapeutic application | |
CR10912A (es) | Preparacion framaceutica para reducir la endometriosis | |
CL2015003014A1 (es) | Composición farmacéutica que comprende 0,5-5 mg de (11?,17?)-17-hidroxi-11-[4-(metilsulfonil)fenil]-17-(pentafluoroetil)estra-4,9-dien-3-ona; forma de dosificación oral; uso para tratar y/o prevenir una enfermedad ginecológica, tal como, fibroides en el útero, endometriosis o hemorragias menstruales excesivas. | |
AR053546A1 (es) | Forma farmacologica peroral solida para la anticoncepcion | |
CR9324A (es) | Preparación farmacéutica para la anticoncepción oral | |
AR080541A1 (es) | Tratamiento para la endometriosis | |
AR116592A1 (es) | Tratamiento de la colangitis biliar primaria y la colangitis esclerosante primaria con baricitinib | |
CU20090116A7 (es) | Preparación farmacéutica para reducir la endometriosis | |
PA8793901A1 (es) | Uso de gestágenos en combinación con (6s)-5-metiltetrahidrofolato para la terapia la endometriosis con simultánea reducción de los efectos colaterales terapéuticos, así como reducción del riesgo de malformaciones congénitas al comenzar un embarazo | |
CU20110070A6 (es) | Método para tratar la endometriosis sin disminuir la densidad ósea | |
SI2285367T1 (sl) | Farmacevtski sestavek za zdravljenje bradavic | |
PE20091020A1 (es) | Uso de un gestageno en combinacion con un estrogeno y uno o varios excipientes/portadores farmaceuticamente aceptables para la anticoncepcion oral sin lactosa | |
PE20090479A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente anticonvulsivante y un agente benzodiazepinico, indicada para el control y tratamiento de trastornos convulsivos y sindromes epilepticos | |
UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral | |
AR067699A1 (es) | Composicion farmaceutica que comprende la combinacion de un agente antiandrogenico, un agente estrogenico esteroidico sintetico y agentes vitaminicos, util para el control y tratamiento del acne tardio en la mujer |